M
Manasi Agrawal
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 101
Citations - 1350
Manasi Agrawal is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Inflammatory bowel disease. The author has an hindex of 13, co-authored 54 publications receiving 724 citations. Previous affiliations of Manasi Agrawal include Albert Einstein College of Medicine & Aalborg University – Copenhagen.
Papers
More filters
Journal ArticleDOI
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage.
Pramod K. Mistry,Jun Liu,Mei Yang,Timothy Nottoli,James L. McGrath,Dhanpat Jain,Kate Zhang,Joan Keutzer,Wei-Lien Chuang,Wajahat Z. Mehal,Hongyu Zhao,Aiping Lin,Shrikant Mane,Xuan Liu,Yuan Z. Peng,Jian H. Li,Manasi Agrawal,Ling-Ling Zhu,Harry C. Blair,Lisa J. Robinson,Jameel Iqbal,Li Sun,Mone Zaidi +22 more
TL;DR: Direct evidence is provided for the involvement in GD1 of multiple cell lineages, suggesting that cells other than macrophages may be worthwhile therapeutic targets.
Journal ArticleDOI
The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
Manasi Agrawal,Olga C. Aroniadis,Lawrence J. Brandt,Colleen R. Kelly,Sarah G. Freeman,Christina M. Surawicz,Elizabeth K. Broussard,Neil Stollman,Andrea Giovanelli,Becky A. Smith,Eugene F. Yen,Apurva Trivedi,Levi Hubble,Dina Kao,Thomas J. Borody,Sarah Finlayson,Arnab Ray,Robert Smith +17 more
TL;DR: FMT is a safe and effective treatment option for RCDI, SCDI, and CCDI in elderly patients and new diagnoses post-FMT included microscopic colitis, Sjogren syndrome, follicular lymphoma, and laryngeal carcinoma, all of which were associated with predisposing factors.
Journal ArticleDOI
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.
Jordan E. Axelrad,Jordan E. Axelrad,Oren Bernheim,Jean-Frederic Colombel,Stefano Malerba,Ashwin N. Ananthakrishnan,Vijay Yajnik,Gila Hoffman,Manasi Agrawal,Dana J. Lukin,Amit P. Desai,Elisa McEachern,Brian P. Bosworth,Ellen Scherl,Andre Reyes,Hina Zaidi,Prashant Mudireddy,David Dicaprio,Keith Sultan,Burton I. Korelitz,Erwin Wang,Renee Williams,LeaAnn Chen,Seymour Katz,Steven H. Itzkowitz +24 more
TL;DR: In patients with IBD and a history of cancer, exposure to an anti-TNF agent or an antimetabolite after cancer was not associated with an increased risk of incident cancer, compared with patients who did not receive immunosuppression.
Journal ArticleDOI
Bone, inflammation, and inflammatory bowel disease
Manasi Agrawal,Shitij Arora,Jianjun Li,Rabin Rahmani,Li Sun,Adam F. Steinlauf,Jeffrey I. Mechanick,Mone Zaidi +7 more
TL;DR: The molecular pathways of bone loss mediated by inflammatory cytokines and other mediators are discussed, which will hopefully clarify the mechanisms of inflammation-induced bone loss in IBD and guide effective treatment modalities.
Journal ArticleDOI
Fatigue in Inflammatory Bowel Diseases: Etiologies and Management
TL;DR: The available tools for the diagnosis and measurement of fatigue, etiologies, and recommendations for their management are summarized, and an algorithm to aid physicians in the evaluation and management of fatigue in this unique population of patients with IBD is proposed.